Ficlatuzumab With High Dose Cytarabine in Relapsed and Refractory AML
Clinical trial NCT02109627 · TERMINATED
Trial details
- NCT number
- NCT02109627
- Sponsor
- C. Babis Andreadis
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-05-01
- Primary completion
- 2019-12-02
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.